Baxter to market Merrimack's cancer drug outside U.S.
September 24, 2014 at 08:08 AM EDT
Sept 24 (Reuters) - Drug developer Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market its pancreatic cancer drug outside the United States, sending its shares up as much as 27 percent premarket.
